Eurosystem to evaluate outcomes of wholesale distributed ledger technology (DLT) settlement test in January
The Eurosystem's wholesale DLT settlement trials using central bank money have come to an end last month, marking a significant milestone in the exploration of digital currencies by central banks. The European Central Bank (ECB) has not announced an immediate extension of these trials, but has expressed intentions to discuss the lessons learned with participants in January.
Sixty-four institutions participated in over 40 trials and experiments, conducting more than 200 transactions with a total value of €1.59 billion. The trials and experiments were a collaborative effort, with various participants contributing to the research and development of this innovative technology.
While the trials have concluded, the ECB has not ruled out the possibility of an extension. Some participants have expressed hope for continued trials to maintain momentum in the development of central bank digital currencies (CBDCs). However, the ECB will first consider the lessons learned from the trials before making a decision.
In a separate development, Switzerland's wholesale CBDC pilot was extended by two years before it ended. The Swiss Federal Council made the decision on June 20, 2025, although the specific participating institutions have not been explicitly named in the available information.
As the world continues to explore the potential of digital currencies, the Eurosystem's trials provide valuable insights into the practical applications of DLT settlement using central bank money. The ECB's discussions with participants in January will likely shed more light on the future of CBDCs in the Eurozone.
It is important to note that this article is based on publicly available information, and pro subscribers may have access to complete articles, exclusive industry analysis, and early access to legislative updates.
Stay tuned for more updates as the ECB continues to assess the lessons learned from the Eurosystem wholesale DLT settlement trials and considers the next steps in the development of CBDCs.
Read also:
- MRI Scans in Epilepsy Diagnosis: Function and Revealed Findings
- Hematology specialist and anemia treatment: The role of a hematologist in managing anemia conditions
- Enhancing the framework or setup for efficient operation and growth
- Hydroelectric Power Generation Industry Forecasted to Expand to USD 413.3 Billion by 2034, Projected Growth Rate of 5.8% Compound Annual Growth Rate (CAGR)
%20settlement%20test%20in%20January){kind=link}